Number of Employees: Approximately 570
Marlboro, Líder, Lark, Philip Morris
Welcome to ITABSA, TANASA and PROESA, Philip Morris International’s (PMI) affiliates in Ecuador. We are proud to have offered quality products to Ecuadorian adult smokers for over 38 years.
Since 1973, we have manufactured local and international brands such as Marlboro, Líder, Lark, and Philip Morris. Our factory in Durán processes tobacco, while the Quito factory manufactures cigarettes.
Over 500 employees work at our two factories, administrative offices and 10 sales offices throughout the country. Approximately 800 independent farmers grow tobacco for our companies, mainly in the provinces of Guayas and Los Rios.
Our Corporate Contributions program is active in the local community, and we support numerous programs designed to provide assistance to those in need. For example, improve education facilities in rural areas, provide scholarships for disabled students and also work to alleviate hunger and poverty.
Smoking and Health
Tobacco products, including cigarettes, are dangerous and addictive. There is overwhelming medical and scientific evidence that smoking causes lung cancer, heart disease, emphysema, and other serious diseases.
All tobacco products are addictive. It can be very difficult to quit smoking, but this should not deter smokers who want to quit from trying to do so.
Public health officials have concluded that secondhand smoke from cigarettes causes serious diseases in non-smokers, including lung cancer and heart disease. We believe the public health conclusions on secondhand smoke are sufficient to support smoking restrictions in public places.
Philip Morris International (PMI) supports comprehensive regulation of tobacco products based on the principle of harm reduction.
To be effective, tobacco regulatory policy must be evidence-based, apply to all tobacco products, and should take into account the views of all legitimate stakeholders including public health authorities, government finance authorities, tobacco manufacturers, and other members of the tobacco supply chain. Regulatory policy must consider the potential to trigger adverse consequences which undermine public health objectives, such as increasing the demand for illicit cigarettes.
While we support comprehensive, effective tobacco regulation, we do not support regulation that prevents adults from buying and using tobacco products or that imposes unnecessary impediments to the operation of the legitimate tobacco market. In that regard, we oppose measures such as generic packaging, point of sale display bans, total bans on communications to adult consumers, and bans on the use of all ingredients in tobacco products.